Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pluvicto
Biotech
ESMO: Lantheus' radiotherapy readout not enough to best Pluvicto
Lantheus may have been hoping that “statistically significant” data for its radioligand therapy would make a splash, but not everyone is impressed.
James Waldron
Sep 16, 2024 8:55am
Novartis entrenches into radiopharma with $1B Mariana buy
May 2, 2024 7:00am
How Novartis is disrupting Lilly's $1.4B radiotherapy plan
Dec 5, 2023 11:21am
Novartis knows what's ahead as peers enter radiopharmaceuticals
Oct 24, 2023 7:00am